148
Views
0
CrossRef citations to date
0
Altmetric
Neuromodulation and Interventional

Efficacy and Safety of Loxoprofen Sodium Hydrogel Patch in Patients with Chronic Inflammatory Pain: A 4-Week Real-World Study

ORCID Icon, , ORCID Icon, , &
Pages 535-541 | Received 28 Aug 2023, Accepted 26 Jan 2024, Published online: 04 Feb 2024

References

  • Cieza A, Causey K, Kamenov K, et al. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2021;396(10267):2006–2017. doi:10.1016/S0140-6736(20)32340-0
  • Cooper C, Arden NK. Excess mortality in osteoarthritis. BMJ. 2011;342:d1407. doi:10.1136/bmj.d1407
  • Shi C, Ye Z, Shao Z, et al. Multidisciplinary guidelines for the rational use of topical non-steroidal anti-inflammatory drugs for musculoskeletal pain (2022). J Clin Med. 2023;12(4):1544. doi:10.3390/jcm12041544
  • Buckle P. Ergonomics and musculoskeletal disorders: overview. Occup Med. 2005;55(3):164–167. doi:10.1093/occmed/kqi081
  • Chen N, Fong D, Wong J. Trends in musculoskeletal rehabilitation needs in china from 1990 to 2030: a bayesian age-period-cohort modeling study. Front Public Health. 2022;10:869239. doi:10.3389/fpubh.2022.869239
  • Paoloni JA, Milne C, Orchard J, Hamilton B. Non-steroidal anti-inflammatory drugs in sports medicine: guidelines for practical but sensible use. Br J Sports Med. 2009;43(11):863–865. doi:10.1136/bjsm.2009.059980
  • Zhao D, Chen Z, Hu S, et al. Efficacy and safety of loxoprofen hydrogel transdermal patch versus loxoprofen tablet in Chinese patients with myalgia: a double-blind, double-dummy, parallel-group, randomized, controlled, non-inferiority trial. Clin Drug Investig. 2019;39(4):369–377. doi:10.1007/s40261-019-00756-x
  • Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061–1075. doi:10.2147/TCRM.S79135
  • Scarpignato C, Lanas A, Blandizzi C, et al. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med. 2015;13(1):55. doi:10.1186/s12916-015-0285-8
  • Scheiman JM. NSAID-induced gastrointestinal injury: a focused update for clinicians. J Clin Gastroenterol. 2016;50(1):5–10. doi:10.1097/MCG.0000000000000432
  • Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S18–S21. doi:10.1016/j.semarthrit.2015.11.007
  • Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, Hip, and knee. Arthritis Care Res. 2012;64(4):465–474. doi:10.1002/acr.21596
  • Bruyere O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3–S11. doi:10.1016/j.semarthrit.2015.11.010
  • Arakawa T, Fujiwara Y, Sollano JD, et al. A questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007. Digestion. 2009;79(3):177–185. doi:10.1159/000211713
  • Fan M, Cao S, Tu L, et al. Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: a 4-week randomized, open-label study. Biomed Rep. 2019;10(6):331–336. doi:10.3892/br.2019.1209
  • Fujiki EN, Netto NA, Kraychete DC, et al. Efficacy and safety of loxoprofen sodium topical patch for the treatment of pain in patients with minor acute traumatic limb injuries in Brazil: a randomized, double-blind, noninferiority trial. Pain. 2019;160(7):1606–1613. doi:10.1097/j.pain.0000000000001549
  • Mu R, Bao CD, Chen ZW, et al. Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: a randomized controlled non-inferiority trial. Clin Rheumatol. 2016;35(1):165–173. doi:10.1007/s10067-014-2701-4
  • Liu F, Panagiotakos D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol. 2022;22(1):287. doi:10.1186/s12874-022-01768-6
  • Andrade C. Real world studies: what they are and what they are not. Indian J Psychol Med. 2023;45(5):537–538. doi:10.1177/02537176231188563
  • Grimes DA, Hubacher D, Nanda K, et al. The good clinical practice guideline: a bronze standard for clinical research. Lancet. 2005;366(9480):172–174. doi:10.1016/S0140-6736(05)66875-4
  • Greig SL, Garnock-Jones KP. Loxoprofen: a Review in Pain and Inflammation. Clin Drug Investig. 2016;36(9):771–781. doi:10.1007/s40261-016-0440-9
  • Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60(3):555–574. doi:10.2165/00003495-200060030-00004
  • Lionberger DR, Brennan MJ. Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch. J Pain Res. 2010;3:223–233. doi:10.2147/JPR.S13238